Aktionärsstruktur

Inhaber in %
Capital Research & Management Co. (World Investors) 4,16
Investor AB (Investment Company) 4,07
BlackRock Investment Management (UK) Ltd. 3,41
Wellington Management Co. LLP 3,17
The Vanguard Group, Inc. 2,85
Legal & General Investment Management Ltd. 2,20
Norges Bank Investment Management 2,18
BlackRock Fund Advisors 1,70
Fidelity Management & Research Co. 1,67
Dodge & Cox 1,32
BlackRock Advisors (UK) Ltd. 1,13
Threadneedle Asset Management Ltd. 1,04
SSgA Funds Management, Inc. 0,96
BlackRock Advisors LLC 0,91
M&G Investment Management Ltd. 0,91

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2014 2015 2016 2017 2018
Personal am Ende des Jahres 57.500 61.500 59.700 61.100 64.400
Umsatz pro Mitarbeiter in Mio. EUR 0,28 0,26 0,29 0,29 0,26

Bilanz (in Mio. EUR) - Aktiva

2014 2015 2016 2017 2018
Summe Umlaufvermögen 10.607 10.739 10.523 9.524 12.184
Summe Anlagevermögen 19.541 22.758 25.624 24.223 24.797
Summe Aktiva 37.579 40.792 50.602 46.833 47.622

Bilanz (in Mio. EUR) - Passiva

2014 2015 2016 2017 2018
Gesamtverschuldung/ -verbindlichkeiten 6.953 10.213 13.602 13.163 15.007
Summe Fremdkapital 24.979 28.235 37.112 34.531 36.595
Summe Eigenkapital 12.600 12.558 13.490 12.302 11.027
Summe Passiva 37.579 40.792 50.602 46.833 47.622

Adresse

Cambridge Biomedical Campus, CB2 0AA Cambridge
Telefon 442037495000
Fax 441223352858
Internet http://astrazeneca.com

Management

Adrian Charles Noel Kemp
Secretary
Colin Reisner, MD
Head-Clinical Respiratory
David Fredrickson
EVP, Global Head-Oncology Business Unit
Deborah DiSanzo, MBA
Non-Executive Director
Edward Bradley
Senior VP & Head-Innovative Medicines Oncology
Fiona Cicconi
Executive Vice President-Human Resources
Geneviéve B. Berger MD, PhD
Independent Non-Executive Director
Graham Andrew Chipchase
Senior Independent Non-Executive Director
Jeffrey Pott
General Counsel
José Baselga MD, PhD
EVP-Research & Development for Oncology
Katarina Ageborg
Chief Compliance Officer & EVP-Sustainability
Leif Valdemar Johansson
Non-Executive Chairman
Marc Pierre Jean Dunoyer, MBA
Chief Financial Officer & Executive Director
Marcus Wallenberg
Independent Non-Executive Director
Menelas N. Pangalos, PhD
EVP-Research & Development Biopharmaceuticals
Nazneen Rahman, PhD
Non-Executive Director
Pam P. Cheng, MBA
Executive VP-Operations & Information Technology
Pascal Soriot PhD, MBA
Chief Executive Officer & Executive Director
Philip Arthur John Broadley
Non-Executive Director
Rob Skelding
Global Director-Media Relations
Ruud Dobber, PhD
Executive VP-Biopharmaceuticals Business
Sherilyn S. McCoy, MBA
Non-Executive Director
Thomas Kudsk Larsen
Investor Relations Contact
Tony Mok
Non-Executive Director